Cardio Diagnostics (CDIO) vs Imunon (IMNN)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Imunon is the larger company by market cap ($6.0 million vs $5.5 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Head-to-head
| Metric | CDIO | IMNN |
|---|---|---|
| Share price | $1.86 | $1.07 |
| Market cap | $5.50M | $6.00M |
| 1-day change | -5.58% | -4.46% |
| EPS (TTM) | $-2.91 | $-3.84 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $7.91 | $5.39 |
| 52-week low | $0.97 | $1.03 |
| Distance from 52-week high | -76.49% | -80.15% |
| Analyst consensus | — | strong_buy |
| Avg. price target upside | — | +1488.79% |
| Average volume | 56.01K | 155.30K |
| Shares outstanding | 2.96M | 5.61M |
| Employees | 15 | 20 |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Cardio Diagnostics
CDIO stock →Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease.
Healthcare · Biotechnology · 15 employees
About Imunon
IMNN stock →Imunon, Inc., a clinical-stage biotechnology company, focuses on developing immunotherapies and vaccines in the United States. The company's lead clinical program is IMNN-001, a DNA-based immunotherapy that is in a Phase 3 clinical trial for the localized treatment of advanced ovarian cancer, as well as in the IND-enabling phase for colorectal and pancreatic cancers, and in the discovery phase for glioblastoma.
Healthcare · Biotechnology · 20 employees
CDIO vs IMNN FAQ
Which is bigger, Cardio Diagnostics or Imunon?
Imunon (IMNN) is larger, with a market capitalization of $6.00M compared with $5.50M for Cardio Diagnostics (CDIO).
Are Cardio Diagnostics and Imunon in the same industry?
Yes. Both are classified in the Biotechnology industry within the Healthcare sector.